These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 38492634)
1. Notoginsenoside R1 targets PPAR-γ to inhibit hepatic stellate cell activation and ameliorates liver fibrosis. Guo C; Lai L; Ma B; Huang Q; Wang Z Exp Cell Res; 2024 Apr; 437(1):113992. PubMed ID: 38492634 [TBL] [Abstract][Full Text] [Related]
2. Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-γ/STAT1/Smad7 pathway. Guo M; Wang Z; Dai J; Fan H; Yuan N; Gao L; Peng H; Cheng X Phytomedicine; 2023 Apr; 112():154587. PubMed ID: 36805480 [TBL] [Abstract][Full Text] [Related]
4. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation. Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665 [TBL] [Abstract][Full Text] [Related]
5. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway. Ni XX; Li XY; Wang Q; Hua J J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625 [TBL] [Abstract][Full Text] [Related]
6. Notoginsenoside R1, An Active Compound from Gong X; Shan L; Cao S; Li K; Wu Y; Zhang Q Am J Chin Med; 2022; 50(2):511-523. PubMed ID: 35114912 [TBL] [Abstract][Full Text] [Related]
7. Proanthocyanidin A2 attenuates the activation of hepatic stellate cells by activating the PPAR-γ signalling pathway. Xiao Y; Li X; Wang L; Hu M; Liu Y Autoimmunity; 2023 Dec; 56(1):2250101. PubMed ID: 37615088 [TBL] [Abstract][Full Text] [Related]
8. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway. Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275 [TBL] [Abstract][Full Text] [Related]
9. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling. Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890 [TBL] [Abstract][Full Text] [Related]
10. Jiawei Taohe Chengqi Decoction attenuates hepatic fibrosis by preventing activation of HSCs through regulating Src/ERK/Smad3 signal pathway. Huang Y; Wang ZL; He Y; Ye LM; Guo WQ; Zhang JJ J Ethnopharmacol; 2023 Apr; 305():116059. PubMed ID: 36549368 [TBL] [Abstract][Full Text] [Related]
11. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways. Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783 [TBL] [Abstract][Full Text] [Related]
12. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways. Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452 [TBL] [Abstract][Full Text] [Related]
13. N-n-Butyl haloperidol iodide ameliorates liver fibrosis and hepatic stellate cell activation in mice. Shen DF; Cheng H; Cai BZ; Cai WF; Wang B; Zhu Q; Wu YB; Liu M; Chen RJ; Gao FF; Zhang YM; Niu YD; Shi GG Acta Pharmacol Sin; 2022 Jan; 43(1):133-145. PubMed ID: 33758354 [TBL] [Abstract][Full Text] [Related]
14. Baihe Wuyao decoction ameliorates CCl Chen Y; Li R; Hu N; Yu C; Song H; Li Y; Dai Y; Guo Z; Li M; Zheng Y; Guo Z; Qi Y J Ethnopharmacol; 2020 Dec; 263():113227. PubMed ID: 32783983 [TBL] [Abstract][Full Text] [Related]
15. GLIS2 Prevents Hepatic Fibrosis by Competitively Binding HDAC3 to Inhibit Hepatic Stellate Cell Activation. Zhang H; Zhou P; Xing W; Chen L; Zhou Y; Yang H; Fu K; Liu Z Cell Mol Gastroenterol Hepatol; 2023; 15(2):355-372. PubMed ID: 36397300 [TBL] [Abstract][Full Text] [Related]
16. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway. Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574 [TBL] [Abstract][Full Text] [Related]
17. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling. Perumal N; Perumal M; Halagowder D; Sivasithamparam N Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397 [TBL] [Abstract][Full Text] [Related]
18. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2. Yu F; Chen B; Fan X; Li G; Dong P; Zheng J Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595 [TBL] [Abstract][Full Text] [Related]
19. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling. Chen C; Chen J; Wang Y; Fang L; Guo C; Sang T; Peng H; Zhao Q; Chen S; Lin X; Wang X Phytomedicine; 2023 Feb; 110():154626. PubMed ID: 36603342 [TBL] [Abstract][Full Text] [Related]
20. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation. Yang JW; Hien TT; Lim SC; Jun DW; Choi HS; Yoon JH; Cho IJ; Kang KW J Hepatol; 2014 Jun; 60(6):1235-41. PubMed ID: 24530597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]